Stock futures rise as Iran peace talk prospects improve, oil drops under $100, and JPMorgan reports 13% profit gain to launch earnings season.
Author: Trader Edge
Read More
BYD stock dipped 0.6% after a fire at its Shenzhen Pingshan facility affected a test vehicle parking garage. No casualties were reported.
ASML stock has jumped 40% in 2026. Q1 earnings arrive Wednesday with analysts expecting strong results and possible guidance increases. Full preview inside.
Travere Therapeutics (TVTX) stock rallied 44% after FDA approved FILSPARI for FSGS, a rare kidney disease affecting over 30,000 U.S. patients.
Deutsche Börse acquires 1.5% of Kraken for $200M, valuing the crypto exchange at $13.3B. Traditional financial institutions increase digital asset exposure.
BMW Q1 2026 deliveries fell 3.5% to 565,748 units. China dropped 10%, U.S. declined 4.3%, while Europe rose 3%. EV sales show mixed results globally.
Robinhood (HOOD) shares have fallen 53% from highs, but Bernstein stays bullish with a $130 target. Analyst views diverge as insiders sell stock.
BlackRock (BLK) stock rallied 2.4% after reporting Q1 EPS of $12.53, beating estimates. Revenue surged 27% to $6.7B with record ETF inflows of $132B.
Globalstar (GSAT) stock soared ~16% premarket as Amazon pursues a ~$9B takeover. Apple’s 20% stake adds complexity to the satellite deal.
Citi (C) and BlackRock (BLK) stocks rally as both firms upgrade US equities to overweight, citing robust earnings growth and diminishing Iran conflict risks.
CarMax (KMX) stock falls 6.8% after reporting Q4 loss from $141M goodwill charge, despite beating estimates. Per-vehicle margins continue shrinking.
Lucid (LCID) stock surges 11% on $750M investment from PIF affiliate and Uber, expanded 35,000-vehicle robotaxi deal, and new CEO Silvio Napoli announcement.
JPMorgan Chase (JPM) stock climbs after reporting Q1 earnings of $5.94 per share, beating estimates with net income up 13% and trading revenue jumping 20%.
Johnson & Johnson (JNJ) stock advances after Q1 2026 earnings surpass forecasts with $24.1B sales, elevated guidance, and robust pharmaceutical performance.
Wells Fargo (WFC) shares fell 1.7% premarket despite beating Q1 earnings expectations, as revenue of $21.45B missed the $21.76B analyst estimate.